AI-generated analysis. Always verify with the original filing.
NeoGenomics, Inc. reported Q4 2025 consolidated revenue of $190 million, up 11% from Q4 2024, and full year 2025 revenue of $727 million, up 10% from 2024. The company issued 2026 guidance for revenue of $793-$801 million and adjusted EBITDA of $55-$57 million.
Event Type
Disclosure
Mandatory
Variant
8-K
Results of Operations and Financial Condition. On February 17, 2026 , NeoGenomics, Inc. issued a press release reporting its results for its fourth fiscal quart
Financial Statements and Exhibits. (a) Not applicable (b) Not applicable (c) Not applicable (d) Exhibits. 99.1 Press Release of NeoGenomics, Inc. dated February
| Metric | Value | Basis |
|---|---|---|
| Revenue | $727.3K | |
| Net Loss | $108.0K | GAAP |
| Adjusted EBITDA | $43.0K | Non-GAAP |
| Adjusted Net Income | $15.0K | Non-GAAP |
Consolidated revenue
801
Net loss
50
GAAP
Adjusted EBITDA
57
Non-GAAP